Maternal use of antenatal corticosteroids for fetal lung maturation and other preterm birth-related complications ranged from 16% to 91% among 29 countries, according to a study in the journal The Lancet. Nearly half of women who were potentially eligible for tocolysis agents to delay delivery did not receive any treatment, while 27% were just treated with bed rest.

Related Summaries